Key Takeaways
- Double-digit revenue, muted volume: Revenue grew 12.7% but volume growth was only 4.8%, signalling price-led expansion as commodity costs rose; gross margins held steady with a slight upward tilt.
- Personal Care is the consistent engine: The segment has delivered double-digit growth for 7 straight quarters, driven by category-building in market-leader brands Everyuth and Nycil.
- Food & Nutrition dragged by Complan: Segment growth is weighed down by Complan, a large but low-growth brand, plus inflationary pressure on consumption in that category.
- Margin recovery story still has legs: Gross margins have recovered what was lost between FY21 and FY23, and management sees further scope to improve; the target is 17–18% EBITDA in 6–8 quarters.
- What to watch next quarter: Whether the summer season delivers its outsized profit contribution, the pace of price increases across commodity-led products, and any sign that urban demand is reviving.
Topline & Volume Dynamics
- Price-led growth: Revenue growth of 12.7% on volume growth of 4.8% reflects price increases taken across multiple products where commodity costs rose, largely in commodity-led products.
- Urban demand sluggish: Muted FMCG demand with green shoots in some categories; rural consumption expanded steadily while urban demand remains soft, though management expects the setback to be temporary.
- Small packs gaining share: Small unit packs are growing faster, particularly in Personal Care where low unit price and consumer preference for one-time-use packs drive the trend.
- Online channel outperforming: E-commerce and modern trade contribute 10–11% of revenue and are growing much faster than the rest of the business, with market shares higher in these channels.
- Channel profitability balanced: Cost to serve is fairly comparable across channels; general trade has higher profitability but higher cost to serve from a large field force, while e-commerce offsets with bigger pack sizes and higher per-unit profit.
- Working capital to rise: As the proportion of e-commerce and modern trade increases, working capital intensity will rise even if margins stay stable, a secular trend management expects to continue in the medium term.
Arora: "We are hopeful that we'll continue this double-digit journey and execute well on our existing brands as well as new product portfolio."
Segment Performance
| Segment | Trend | Commentary |
|---|---|---|
| Personal Care | ▲ Strong | Double-digit growth for 7 quarters; Everyuth and Nycil are market leaders; new products like Pink Clay and charcoal range gaining traction. |
| Food & Nutrition | ▬ Mixed | Glucon-D delivered double-digit growth over 3–4 years, targeting category expansion from ₹1,100 cr to ₹1,500 cr; Complan is a drag as a large, low-growth brand. |
| Sugar Free Green | ▲ Strong | Strong double-digit growth driven by increasing volume uptake. |
| Nutralite | ▲ Improving | Continued upward trajectory from digital and on-ground activations; launched AI-powered recipe platform. |
| Naturell | Early stage | One month of performance included post-acquisition; pre-acquisition margins were 3–5%, with synergy expected to lift them materially. |
- Category-building over share-grabbing: Most brands are market leaders, so strategy focuses on expanding the category through penetration and consumption rather than taking share from competitors.
Margin Trajectory
- Gross margin recovery complete: Gross margins have improved like-for-like over the previous year for 6–7 quarters, recovering what was lost between FY21 and FY23; October–December numbers matched the same period in FY21.
- Recovery funded advertising: Part of the gross margin improvement was invested back into advertising, but that investment pace will not necessarily continue at the same rate going forward.
- Levers still available: Pricing is the number-one lever when costs rise; sourcing opportunities and reformulation also contribute, though reformulation is a long-run process.
- Cost efficiency program in place: Manufacturing and supply chain teams run a "fairly stiff" cost efficiency program, with the Zydus Group also running a strong program, though specific annual run-rate targets are not disclosed.
- Raw material hedging: Buying forward is done category by category; for palm oil, the procurement team may forward-buy based on Malaysian forward numbers if conditions are favourable, but refined palm oil is bought locally.
Arora: "We do believe that there is still scope for us to continue. We believe our journey is still not completed where we have stabilized. It's still going to go up."
Seasonality & Profit Structure
- Q4 and Q1 dominate profits: These two quarters constitute 85–90% of total annual profits, a pattern management does not expect to change in the short to medium term.
- Q4 tax dynamics: About ₹3.5–4 crores of deferred tax liability will be recorded in Q4; the effective tax rate will fall significantly because of higher profit before tax in that quarter.
- Tax rate shift ahead: The effective tax rate shifts to 21% from FY27.
- Summer season optimism: Management remains optimistic about Q4 given the last four quarters of business performance, though early days prevent specifics.
New Initiatives & Digital Bets
- Naturell acquisition closed: 100% equity acquired; one month of performance included in Q3 results; new product launches include choco-filled fiber bars, melting chocolate, fruit-filled bars, and protein bar bytes.
- Nutralite DoodhShakti extension: Professional range expanded into processed cheese.
- AI-powered recipe platform: Nutralite Chef AI lets consumers get recipe recommendations based on ingredients or ideas, with Nutralite product suggestions built in.
- Sales force digital tool: A data and analytics-based recommendation engine deployed for 1,500–1,600 salesmen at the last mile, suggesting what to sell more in each outlet based on its profile.
- Protein range early days: Management is optimistic about protein chips and cookies; full-quarter results will be available at Q4 to share more colour.
Arora: "Prior to acquisition, we saw a 3% to 5% kind of margins, but with synergy and scale and our work with them, we obviously expect the margins to grow in -- to a much higher level. And we believe FY '26, we could have an EPS accretive on this business."
Competitive & Strategic Context
- Amul's entry seen as validation: On Amul launching a butter substitute under the Delicious brand, management noted that a dairy major moving into butter substitutes signals Zydus is doing something meaningful enough to impact Amul's business.
- Growth ahead of industry: Management is focused on driving growth ahead of the industry, with government showing signs of supporting consumption and movement visible in rural areas.
- True North stake unresolved: When asked about the private equity shareholder's selling plans, management said they are not privy to True North's plans and directed the question to the shareholder directly.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Double-digit top-line growth | FY26 |
| EBITDA growth | In sync with or faster than top-line growth | FY26 |
| EBITDA margin | 17–18% | Next 6–8 quarters |
| Naturell profitability | EPS accretive | FY26 |
| Effective tax rate | Shift to 21% | FY27 onwards |
| Deferred tax liability | ~₹3.5–4 crores recorded in Q4 | Q4 FY25 |
| Seasonal profit structure | 85–90% of profits in Q4 and Q1; no change expected | Short to medium term |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Consolidated net sales | ₹450.8 cr, +12.7% YoY |
| Volume growth | 4.8% YoY |
| EBITDA | ₹14.8 cr, +16.5% YoY |
| Net profit after tax | ₹6.4 cr |
| Personal Care segment growth | 50.3% YoY |
| Food & Nutrition segment growth | 8.8% YoY |
| Gross margin | Steady with slight upward trajectory both sequentially and YoY; October-December gross margins reasonably matched October-December 2021 levels |
| EBITDA margin trajectory | EBITDA growth faster than top-line growth for last 2 quarters; 9-month margin improvement of more than 200 bps largely from June quarter |
| Revenue from online platforms | 10% to 11% of total revenue |
| Food service (HoReCa) channel share | 8% to 10% of overall sales |
| Everyuth scrub market share | 47.3% in facial scrub category, +418 bps YoY at MAT level |
| Everyuth peel off market share | 77.8%, +106.7 bps YoY at MAT level |
| Nycil market share | 33.9% in prickly heat powder category, number one position at MAT level |
| Glucon-D market share | 58.9% in glucose powder category at MAT level |
| Sugar Free market share | 95.4% in sugar substitute category at MAT level |
| Complan market share | 4.1% in nutrition category at MAT level |
| Naturell (Ritebite) acquisition contribution | Low single-digit share of top line, operated at breakeven EBITDA level |
| Deferred tax liability | ₹3.5 cr to ₹4 cr recorded in Q3, similar amount expected in Q4 |
| Effective tax rate shift to 21% | Expected from FY '27 |
| FY26 guidance | Double-digit growth on top line, EBITDA growth in sync or faster than top line growth |